Work

Comparison of methods for the assessment of HIV-1 susceptibility to broadly neutralizing antibodies

Year: 2026
Type: article
Abstract: Broadly neutralizing antibodies (bNAbs) are being developed for the prevention, treatment, and cure of HIV-1. The efficacy of a bNAb is dependent upon the susceptibility of an individual’s virus to the administered bNAb, which can be assessed phenotypically or genotypically. Both methods require cut-offs for susceptibility classification; however, clinical cut-offs for bNAb susceptibility have not been established. In this study, we assessed susceptibility to the two HIV-1 bNAbs 3BNC117 and 10–1074 among 59 newly diagnosed people living with HIV-1 using one phenotypic and four genotypic susceptibility assessment methods. We show that the methods employed and cut-offs assigned can greatly affect the susceptibility prediction. By evaluating the decay in plasma viral load for participants receiving 3BNC117 at ART initiation, clinically relevant cut-offs for susceptibility were identified using an exploratory approach, and application of these cut-offs resulted in 68%–76% of the viruses being correctly classified. No clinical data were available to set cut-offs for susceptibility to 10-1074. Instead, the methods were compared, and consensus-derived cut-offs were set, which resulted in concordant susceptibility assessments for 84% of the participants. In conclusion, our study underlines the importance of the chosen method and cut-off when assessing an individual’s virus susceptibility to HIV-1 bNAbs. Furthermore, we propose cut-offs for bNAb susceptibility to guide the design of future clinical trials.
Language: English
Subfield: Virology
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234813229
FWCI:
Cites: 43
Cited by:
Related to: 10
Parts: 1